| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |